Use access key #2 to skip to page content.
$2.21 0.13 (6.25%)
7/8/2008 4:00 PM

ATS Medical, Inc. (ATSI)

CAPS Rating:
****

The Company develops, manufactures and markets medical devices for use by cardiovascular or cardiothoracic surgeons during cardiac surgery.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating ATSI

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

82 Outperforms
2 Underperforms
 

All-Stars

21 Outperforms
1 Underperforms
 

Wall Street

3 Outperforms
0 Underperforms
 

Players bullish on ATSI are also bullish on:

Players bearish on ATSI are also bearish on:

Ticker Tags

Micro Cap (4824), Medical Appliances & Equipment (106)
Suggest a tag

ATS Medical, Inc. At A Glance

Current Price: $2.21
Last Trade Time: 7/8/2008 4:00 PM
Open: $2.12
Previous Close: $2.08
Daily Range: $2.07 - $2.21
52-Week Range: $1.36 - $2.41
Volume: 138,729
Market Cap: $129.09M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

ATSI VS S&P 500 (SPY)

ATSI 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for ATSI

More Headlines...

Top Bull Pitch

Recs

2

ATS Medical, Inc. (ATSI)

Avatar defender418 (< 20) Submitted: 1/11/08 10:30 PM

ATS Medical has acquired other companies, expanding their ability to serve the cardiovascular field and meet those needs., i.e. 3f Therapeutics. The company has definitely made strides working toward a profitable year in 2008.

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 13 :   1 2 3 Next »

Recs

0

 (ATSI)

Avatar monikasfantasy (< 20) Submitted: 6/30/08 9:22 AM : Outperform Start Price: $2.05 ATSI Score: 8.38

importan heart parts

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ATSI)

Avatar Tadipar8 (< 20) Submitted: 6/16/08 3:01 AM : Outperform Start Price: $2.37 ATSI Score: -0.07

The stock has more potential, and will beat the anylist forcaste in Second qtr 2008. Also will be profitable by end of 2008.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ATSI)

Avatar JohnnyiPhone (23.80) Submitted: 6/13/08 8:01 AM : Outperform Start Price: $2.38 ATSI Score: -1.72

Member of the "Mini-Cap Monsters."

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ATSI)

Avatar vemdnm (40.92) Submitted: 6/11/08 12:09 PM : Outperform Start Price: $2.30 ATSI Score: 1.89

Baby boomers becoming granpama boomers!!! Life expectancy of grandpama boomers also expected to increase. One thing only, more medical health care needed, more cardiovascular issues etc. This company should see lots of growth within the next five years.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ATSI)

Avatar Meridians (52.82) Submitted: 5/27/08 7:18 PM : Outperform Start Price: $2.05 ATSI Score: 16.29

Develops products and services for cardiac procedures and surgery.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 13 :   1 2 3 Next »

Wall Street

Results 1 - 3 of 3  

picks per page. CHANGE

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackCanaccord 89.18 05/06/08 05/06/08 Outperform NS $2.03+8.87%-9.93%+18.79
TrackRodmanRen < 20 02/28/08 02/28/08 Outperform NS $1.69+30.77%-7.32%+38.08
TrackRBCCapMkts 88.15 02/01/08 02/01/08 Outperform NS $1.65+33.94%-7.79%+41.73

Results 1 - 3 of 3  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners